Live News Reader

Some of the articles presented on this website are accessed through RSS feeds from third-party sources that are not necessarily part of the Histiocytosis Association. While we try to select appropriate feeds to prevent objectionable content from being displayed, the presence of any article does not indicate endorsement or recommendation by the Histiocytosis Association.

If you know of a histio-related article that isn't shown here, please send the article to outreach@histio.org.

"Erdheim-Chester disease" - Google News
Global Erdheim Chester Disease Treatment Market 2020 Anticipated to Grow at an Impressive Rate by 2026 with Top Key Players like Aphena Pharma Solutions, Pfizer,Bausch Health - MENAFN.COM
Global Erdheim Chester Disease Treatment Market 2020 Anticipated to Grow at an Impressive Rate by 2026 with Top Key Players like Aphena Pharma Solutions, Pfizer,Bausch Health  MENAFN.COM
Wednesday, August 12, 2020

June 2020 Global Erdheim Chester Disease Treatment Coronavirus Impact Editon of COVID 19 Impact Analysis Updated Edition Top Players Include, Bausch Health, Novartis, Aphena Pharma Solutions, Cadila Healthcare, Pfizer - Galus Australis
June 2020 Global Erdheim Chester Disease Treatment Coronavirus Impact Editon of COVID 19 Impact Analysis Updated Edition Top Players Include, Bausch Health, Novartis, Aphena Pharma Solutions, Cadila Healthcare, Pfizer  Galus Australis
Friday, August 14, 2020 3:21:59 AM

Global Erdheim Chester Disease Treatment Market Report 2020 - Bulletin Line
Global Erdheim Chester Disease Treatment Market Report 2020  Bulletin Line
Friday, July 31, 2020 5:57:00 AM

Erdheim Chester Disease Treatment Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2020-2026 | Bausch Health, Cadila Healthcare, SANIS - Bulletin Line
Erdheim Chester Disease Treatment Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2020-2026 | Bausch Health, Cadila Healthcare, SANIS  Bulletin Line
Sunday, August 9, 2020 4:09:00 AM

ROBUST GROWTH OF THE Erdheim Chester Disease Treatment MARKET PREDICTED OVER THE FORECAST PERIOD 2015 – 2021 - Bulletin Line
ROBUST GROWTH OF THE Erdheim Chester Disease Treatment MARKET PREDICTED OVER THE FORECAST PERIOD 2015 – 2021  Bulletin Line
Friday, August 7, 2020 2:06:00 PM

UAB joins the Erdheim-Chester Disease Care Center Network - UAB News
UAB joins the Erdheim-Chester Disease Care Center Network  UAB News
Tuesday, February 25, 2020 3:00:00 AM

Trending News: Erdheim Chester Disease Treatment Market Overview and Forecast Report 2020-2026 – Top players: Bausch Health,Cadila Healthcare,SANIS,Aphena Pharma Solutions,Roche,Cardinal Health,Pfizer,Novartis - The Daily Chronicle
Trending News: Erdheim Chester Disease Treatment Market Overview and Forecast Report 2020-2026 – Top players: Bausch Health,Cadila Healthcare,SANIS,Aphena Pharma Solutions,Roche,Cardinal Health,Pfizer,Novartis  The Daily Chronicle
Thursday, August 6, 2020 3:36:17 PM

FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer - FDA.gov
FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer  FDA.gov
Monday, November 6, 2017 3:00:00 AM

Largest Study of Its Kind Reveals New Targetable Genetic Causes of the Rare Blood Disorder Histiocytosis - On Cancer - Memorial Sloan Kettering
Largest Study of Its Kind Reveals New Targetable Genetic Causes of the Rare Blood Disorder Histiocytosis  On Cancer - Memorial Sloan Kettering
Wednesday, December 4, 2019 3:00:00 AM

FDA Approves Vemurafenib for Treating Erdheim-Chester Disease - Cancer Network
FDA Approves Vemurafenib for Treating Erdheim-Chester Disease  Cancer Network
Thursday, November 9, 2017 3:00:00 AM

Share with Others

© Histiocytosis Association, Inc.
332 North Broadway, Pitman, New Jersey  08071 USA
Phone: +1 856-589-6606 | Fax: +1 856-589-6614
| info@histio.org
US & Canada Toll-Free: 1-800-548-2758 
Privacy | DisclaimerState Fundraising Notices 
Tax ID: 22-2827069 | Contact Us 
Follow Me on Pinterest   


¿No Habla Inglés? Si usted puede escribirme sus preguntas y preocupaciones a la dirección de correo electrónico: outreach@histio.org. Nosotros podremos responderle tan pronto nos sea possible. Gracias!